Human gene
SLC25A12 solute carrier family 25 (aspartate/glutamate carrier), member 12
2 disease groups in OMIA reach this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 2294 | Cerebellar degeneration-myositis complex, SLC25A12-related | dog | SLC25A12 | one to one | Target evidence |
57.0
|
| 3026 | Porencephaly, SLC25A12-related | domestic cattle | SLC25A12 | one to one | Target evidence |
57.0
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| developmental and epileptic encephalopathy, 39 | MONDO:0013056 | 0.80 | 49 |
Drugs
Each ChEMBL drug that acts on this gene.
No ChEMBL drug acts on this gene, among the genes with target evidence.